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a b s t r a c t
Vascularization is the most pressing issue in tissue engineering (TE) since ensuring that engineered con-
structs are adequately perfused after in vivo transplantation is essential for the construct’s survival. The
combination of endothelial cells with current TE strategies seems the most promising approach but
doubts persist as to which type of endothelial cells to use. Umbilical cord blood (UCB) cells have been
suggested as a possible source of endothelial progenitors. Osteoblasts obtained from human adipose-
derived stem cells (hASCs) were co-cultured with the mononuclear fraction of human UCB for 7 and
21 days on carrageenan membranes. The expression of vWF and CD31, and the DiI-AcLDL uptake ability
allowed detection of the presence of endothelial and monocytic lineages cells in the co-culture for all cul-
ture times. In addition, the molecular expression of CD31 and VE-cadherin increased after 21 days of co-
culture. The functionality of the system was assessed after transplantation in nude mice. Although an
inﬂammatory response developed, blood vessels with cells positive for human CD31 were detected
around the membranes. Furthermore, the number of blood vessels in the vicinity of the implants
increased when cells from the mononuclear fraction of UCB were present in the transplants compared
to transplants with only hASC-derived osteoblasts. These results show how endothelial progenitors pres-
ent in the mononuclear fraction of UCB can be sustained by hASC-derived osteoblast co-culture and con-
tribute to angiogenesis even in an in vivo setting of inﬂammatory response.
 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
1. Introduction
It is well established that vascularization is a critical issue when
engineering a tissue [1,2]. Improper inosculation and blood perfu-
sion after transplantation can result in the failure of an implant
especially if its thickness prevents suitable oxygen and nutrient
diffusion to the transplanted cells. This is a pressing issue in bone
tissue engineering (TE) where typically a 3-D scaffold is seeded
with osteogenic or osteoprogenitor cells, and transplanted in vivo
for subsequent bone formation [1,2]. The current limited clinical
potential of this approach is directly related to deﬁcient vasculari-
zation in vivo, which results in necrosis in the bulk of the scaffold
[1–5]. Therefore, several strategies are being employed to try to
circumvent this important challenge, one of which comprises the
use of endothelial cells to accelerate inosculation and the implant’s
vascularization after transplantation [6].
Endothelial progenitor cells (EPCs) are one type of endothelial
cells that has recently attracted attention. These cells were ﬁrst
isolated from the mononuclear fraction of human peripheral blood
by Asahara et al. [7] but have, since then, also been proven to exist
in the bone marrow [8] and in umbilical cord blood (UCB) [9]. Stud-
ies have shown that EPC transplantation can increase angiogenesis
and vessel formation in different ischemia models [10–13]. UCB is
considered the best source of EPCs since it contains 10 times more
CD34+ cells, one of the markers used to isolate EPCs, than periph-
eral blood [14]. Furthermore, other blood mononuclear cells, such
as monocytes [15,16] and lymphocytes [17], have been shown to
play a positive and essential role in the in vitro formation of EPC
colonies, pointing to a potential advantage of not speciﬁcally iso-
lating CD34+ cells or other subpopulations to obtain EPCs.
The intimate relationship between bone tissue and blood ves-
sels is well studied. Bone formation is always accompanied by
blood vessel development both in embryogenesis and postnatal
growth [18]. Bone multicellular units (BMUs), responsible for bone
remodeling, are always adjacent to a blood vessel that grows as the
BMU advances [19,20]. At the cellular level, endothelial cells have
been proven to modulate the activity of osteoblasts and osteoblast
progenitors by direct and indirect interactions [21–28]. On the
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other hand, osteoblasts are capable of controlling angiogenesis
through the production of factors such as vascular endothelial
growth factor (VEGF) [29–31], which is in turn upregulated when
osteoblasts are in contact with endothelial cells [6]. More impor-
tantly, osteoblasts have been proven to support the maintenance
of cells such as hematopoietic stem cells in several in vitro models
[32,33] by direct contact [32].
Carrageenans (CRGs) are a class of galactan polysaccharides that
behave as extracellular matrix materials, like agars, in speciﬁc spe-
cies of red seaweeds, including Gigartina, Chondrus and Eucheuma
[34–36]. These galactan polysaccharides have been used in many
industrial and some pharmaceutical applications [35,37] and have
been recently proposed for biomedical applications [38–40]. The
CRGs are grouped into several sub-types according to their sulfa-
tion patterns and distribution of 3,6-anhydro-D-galactose residues
[34,35]. In the present work, a kappa–iota hybrid CRG derived from
the seaweed Chondrus crispus was used. This hybrid CRG presents
several processing advantages, including a higher degree of ﬂexi-
bility, when compared to kappa CRG, and a higher robustness
when compared to pure iota CRG [41,42]. Being a naturally occur-
ring hybrid polymer, it behaves as a monocomponent system and
not like a blend, concentrating in a single molecule characteristics
of both kappa and iota types.
Therefore, the aim of this study was to deﬁne a co-culture sys-
tem, using CRG membranes as carriers, composed by hASC-derived
osteoblasts and cells from the mononuclear fraction of UCB by tak-
ing advantage of the osteoblast capacity to generate angiogenic
conditions. The capacity of hASC-derived osteoblasts cultured on
CRGmembranes to support the in vitro survival of human endothe-
lial progenitors present in the mononuclear fraction of UCB was ad-
dressed. The developed systems were then transplanted into nude
mice in order to elucidate their in vivo functionality and therefore
to allow us to consider the potential use of the mononuclear cells
from UCB, without further selection, as a source of endothelial pro-
genitors supported by co-culture with osteoblasts.
2. Materials and methods
2.1. Carrageenan membrane production
CRG-type iota–kappa (hybrid) extracted from the red algae C.
crispus by CEAMSA Company (Spain) was used to produce the
membranes. CRG was dissolved in distilled water to a ﬁnal concen-
tration of 2% w/v. While hot, 25–35 ml of the solutions were placed
in square Petri plates and left to dry at room temperature for 48 h.
To preserve their structural features while cutting, the formed
membranes were placed in a low-hydrating solution of 17% (v/v)
ethanol plus 3% (w/v) KCl (Sigma, USA) and cut into small discs
of 1.1 cm diameter and 1 mm thickness. The CRG membranes were
crosslinked in a water solution of 50% (v/v) 2-propanol (Fluka,
Czech Republic), and 0.32 M KOH (Fluka) and 4.63 mM of epichlo-
rohydrin (ECH, Aldrich, USA) for 24 h, at 37 C under 100 rpm
agitation. The samples were then washed twice with a 17% ethanol
(v/v) and 0.1 M of NaOH (Panreac, Spain) solution, aiming at
blocking the partially reacted ECH and twice with water at 50 C
for 1 h. Each group of CRGmembranes used on each assay was then
sterilized overnight with 70% ethanol. Before cellular assays, the
membranes were maintained in sterile phosphate-buffered saline
(PBS, Sigma) with 3% (w/v) KCl and washed twice in PBS immedi-
ately before cell seeding.
2.2. Cell isolation
UCB and adipose tissue were obtained under cooperation agree-
ments established with 3B’s Research Group and after approval of
the respective Ethical Committees. All samples were obtained with
the agreement of the patients and under total anonymity.
2.2.1. Cord blood mononuclear cells (CBMNCs)
Cord blood was collected during planned caesareans in the
Hospital de São Marcos, Braga, Portugal. Cord was clamped in the
proximity of the abdomen of the newborn and cut. Cord blood
was collected from the vein, before placenta removal, directly to
the collection bag containing CPDA I (Fenway Europe Sprl, Bel-
gium) as anticoagulant. Transport was carried out under tempera-
ture-controlled conditions and samples were processed within 2 h
after collection. The blood was then diluted 2:1 in PBS (Sigma) and
placed over Histopaque 1077 (Sigma) for density gradient centrifu-
gation. For this, 5 ml of Histopaque at room temperature was
placed in a 15 ml conical falcon tube and 3 ml of the cell suspen-
sion was carefully layered over it. The tubes were then centrifuged
at 400g for 30 min at room temperature. Cells in the interface
between plasma and Histopaque were recovered using a Pasteur
pipette, washed three times in PBS (Sigma), counted and used for
establishing the co-culture.
2.2.2. Human adipose derived stem cells (hASCs)
Discarded subcutaneous adipose tissue from liposuction proce-
dures was collected to sterile containers with 100 ml of PBS with
10% antibiotics (Invitrogen, USA) at the Hospital da Prelada, Porto,
Portugal. Lipoaspirates were washed with PBS, in order to discard
the majority of blood, and then digested with 0.05% collagenase
II (Sigma) at 37 C for 45 min. Following that, the digested tissue
was passed through a strainer and centrifuged at 1000g for
10 min at 4 C. The obtained pellet was resuspended in PBS and
centrifuged again at 800g for another 10 min at 4 C. The resulting
pellet was then resuspended in minimum essential medium alpha-
modiﬁcation (alpha-MEM, Invitrogen), supplemented with 10% FBS
(Gibco, USA) and 1% antibiotic–antimycotic (Gibco), ﬁltered with a
100 lm pore size cell strainer (BD Biosciences, USA) and plated in
tissue culture polystyrene ﬂasks, using the culture medium de-
scribed. After 24 h, colonies of spindle-shaped adhered cells started
to appear.
2.3. Flow cytometry
After isolation, CBMNCs were screened by ﬂow cytometry for
the following markers: CD14-PE, CD45-FITC, CD31 APC, CD34-PE
and CD73-PE (all from BD Pharmingen, USA), and CD105-FITC
and CD90-APC (eBiosciences, USA). Cells were resuspended in cold
PBS with 2% (w/v) bovine serum albumin (BSA) (Sigma) and 100 ll
of cell suspension, with 2  105 cells, was incubated with the anti-
bodies at the concentration advised by the manufacturer. After
incubation for 20 min at room temperature in the dark, cells were
washed with PBS/BSA, resuspended in PBS with 1% formaldehyde
(Sigma) and analyzed in a BD FACScalibur ﬂow cytometer (BD Bio-
sciences). Cells of interest were gated in a forward vs. side scatter
dot plot with a linear scale. Isotype controls were made to discern
non-speciﬁc from speciﬁc staining. A minimum of 10,000 gated
events were acquired and displayed in dot plots created using
the Cyﬂogic software (version 1.2.1, CyFlo Ltd., Finland).
2.4. Co-culture set-up
The isolated hASCs at passage 3 were cultured in alpha-MEM
supplemented with osteogenic factors, 108 M dexamethasone
(Sigma), 10 mM beta-glycerophosphate (Sigma) and 50 lg ml1
ascorbic acid (Sigma) for 3 weeks in order to induce differentiation
into the osteogenic lineage. After differentiation (Supplemental
Fig. 1), cells were seeded on the membranes at a concentration of
82  103 cells cm2 that, according to our previous experience
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with mesenchymal stem cells (MSCs) [43], would allow the
cultures to reach conﬂuence after 5 days. Cells were cultured in
M199 medium (Sigma), commonly used to culture primary
endothelial cells, supplemented with 10% FBS, 1% antibiotic–
antimycotic, osteogenic factors, 50 lg ml1 endothelial cell growth
supplement (ECGS, BD Biosciences) and 50 lg ml1 heparin
(Sigma). After this time, the mononuclear cells isolated from cord
blood were seeded on the membranes at a concentration 10-fold
higher than that of hASCs, 82  104 cells cm2, given the reduced
percentage of endothelial progenitors in the total cell number
[44] (and cultured for a further 7 and 21 days in M199 medium
supplemented with 10% FBS, 1% antibiotic–antimycotic, osteogenic
factors, 50 lg ml1 ECGS and 50 lg ml1 heparin). Monocultures of
hASC-derived osteoblasts in the membranes were used as controls.
2.5. DiI-AcLDL uptake assay
After each time point, co-cultures were incubated with
10 lg ml1 of the complex DiI-AcLDL (Invitrogen) for 4 h, at 37 C
and 5% CO2. Cells were then washed with warm medium and ﬁxed
with 3.7% (v/v) buffered formalin (Sigma) for 20 min at room tem-
perature. Cells were then counterstained with DAPI (Invitrogen)
and visualized using an Axioplan Imager Z1 ﬂuorescence micro-
scope (Zeiss, Germany).
2.6. Immunocytochemistry
After each culture time point, the samples were ﬁxed in a 3.7%
(v/v) buffered formalin solution for 30 min at room temperature.
After ﬁxation, cells were washed three times in PBS and used
immediately for immunocytochemistry. Non-speciﬁc binding was
blocked by incubating the membranes with a 3% (w/v) BSA (Sigma)
solution in PBS (Sigma) for 30 min. Cells were then incubated with
the primary antibody diluted in 1% BSA/PBS for 1 h at room tem-
perature. Mouse anti-human CD31 (1:30, Dako, Denmark) and
mouse anti-human vWF (1:100, Dako) primary antibodies were
used. Cells on the membranes were then washed three times with
PBS (Sigma) and incubated for 1 h at room temperature with an
appropriate AlexaFluor (Invitrogen) secondary antibody diluted
1:500. After this time cells were washed in PBS, counterstained
with DAPI, and analyzed in an Axioplan Imager Z1 ﬂuorescence
microscope (Zeiss).
2.7. Quantitative real-time RT-PCR
Messenger RNA (mRNA) of cells was extracted, after each
in vitro time-point, using Tri-reagent (Sigma) according to the
manufacturer’s instructions. 800 ll of the reagent was added per
1  106 cells and samples were homogenized by vigorous pipet-
ting. Following 5 min incubation, 160 ll of chloroform (Sigma)
was added to each sample, which were then incubated for
15 min at 4 C, and then centrifuged at 13,000 rpm and 4 C for
15 min. After centrifugation the aqueous part was collected and
an equal volume of isopropanol (Sigma) was added. Following an
overnight incubation at 20 C, samples were centrifuged at
9000 rpm and 4 C for 10 min. Supernatants were discarded and
pellets were washed in ethanol, centrifuged at 9000 rpm and 4 C
for 5 min and resuspended in 12 ll of RNase/DNase-free water
(Gibco, UK). RNA quantity and purity were assessed with a Nano-
Drop ND-1000 Spectrophotometer (NanoDrop Technologies,
USA). Samples with a 260/280 ratio between 1.6 and 2.0 were used
for cDNA synthesis. The cDNA synthesis was performed using iS-
cript cDNA synthesis Kit (BioRad, USA) and the thermoblock of
the MiniOpticon Real-Time PCR Detection System (BioRad). An ini-
tial amount of 2 lg of mRNA was used in a total volume of 20 ll of
RNase/DNase-free water.
Osteocalcin and osteopontin transcripts were quantiﬁed in the
cDNA samples using a quantitative real-time PCR reaction. For each
sample GAPDH was used as the housekeeping gene. The primers
were designed using Primer 3 software (version 0.4.0) and synthe-
sized by MWG Biotech (Germany) as follows: human GAPDH for-
ward 50 ACA GTC AGC CGC ATC TTC TT30 and reverse 50 GAC AAG
CTT CCC GTT CTC AG 30; human osteocalcin forward 50 GTG CAG
AGT CCA GCA AAG GT 30 and reverse 50TCC CAG CCA TTG ATA
CAG GT 30: human osteopontin forward 50CCC ACA GAC CCT TCC
AAG TA 30 and reverse 50 GGG GAC AAC TGG AGT GAA AA 30; hu-
man collagen I forward 50 AGC CAG CAG ATC GAG AAC AT 30 and
reverse 50 ACA CAG GTC TCA CCG GTT TC 30; human VE-cadherin
forward 50 CAC AGT GCT GGC CAT GGA 30 and reverse 50 GTC
CTG CGG ATG GAG TAT CC 30; human CD31 forward 50 AAG GCC
AGA TGC ACA TCC 30 and reverse 50 TTC TAC CCA ACA TTA ACT
TAG CAG G 30; human vWF forward 50 CCC TGG GTT ACA AGG
AAG AAA AT 30 and reverse 50 AGT GTC ATG ATC TGT CCT CCT
CTT AG 30. A concentration of 200 nM of primer was used in a ﬁnal
volume of 25 ll of sample. The real-time PCR reaction was done
using the iQ Syber Green SuperMix (BioRad), following manufac-
turer’s instructions, in a MiniOpticon Real-Time PCR Detection Sys-
tem (BioRad).
The relative quantiﬁcation of gene expression was performed
using the 2DDCT method (Perkin Elmer User Bulletin No. 2). All
values were ﬁrst normalized against GAPDH values and the results
of the expression of the osteogenic genes in the co-cultures were
normalized using osteoblast monocultures prior to establishing
the co-cultures while the results of the expression of endothelial
genes were normalized using UCBmononuclear cells after isolation
and prior to co-culture.
2.8. In vivo assay
All in vivo assays were performed after consent from the inter-
nal Animal Experimentation Ethical Committee.
Three animals were used per condition, per culture time point
and per implantation time point for a total of 24 animals. Four
week old female Balb/C nude mice with an average weight of
20 g (Charles River Laboratories Inc., USA) were anesthetized with
a mixture of ketamine (1.2 mg/mouse s.c., Imalgene 1000, Merial,
Lyon, France) and medetomidine (20 lg/mouse s.c., Domitor, Or-
ion Corp., Finland) prepared in physiological serum. After the con-
ﬁrmation of analgesia/anesthesia, one incision was performed,
reaching a maximum of 1.5 cm, in the intrascapular region. Two
craniolateral oriented pockets were created by blunt dissection
and the implants were subcutaneously inserted. Two CRG mem-
branes with the same experimental condition were implanted in
each animal. The incisions were sutured and the mice transferred
to heated recovery compartments. When the recovery from anal-
gesia/anesthesia was conﬁrmed, they were returned to their
respective cages and kept under food and drink ad libitum. After
7 and 21 days after implantation, animals were killed with an
intracardiac overdose of anesthesia for implant retrieval, and pro-
cessed for characterization.
2.9. Histology
Standard hematoxylin and eosin (H&E) staining was used to
make a general morphological assessment of the sectioned tissues.
Brieﬂy, sections were deparafﬁnized in xylene (Thermo Scientiﬁc,
USA) and hydrated by incubation with increasingly diluted ethanol
solutions. Sections were then washed in water and incubated with
hematoxylin (Sigma) for 5 min. After this, sections were washed
under running tap water for 10 min and ﬁnally double-distilled
H2O. After incubation with eosin (Sigma) for 1 min, sections were
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dehydrated with ethanol, washed with xylene and mounted with
Histoﬂuid (Marienfeld, Germany).
2.10. Immunohistochemistry
After deparafﬁnization, sections were incubated with antigen
retrieval solution (10 mM sodium citrate, 0.05% Tween 20,
pH 6.0) and heated in a microwave for 2 min at maximum power.
After cooling, sections were incubated with 3% H2O2 for 5 min to
inhibit non-speciﬁc peroxidase activity and washed with PBS.
The next step was to block non-speciﬁc protein interactions by
incubating with a 3% (w/v) BSA solution for 30 min. Sections were
then washed in PBS-tween 20 (PBS-T, Sigma) and incubated with
the mouse anti-human CD31 (1:30, Dako) primary antibody over-
night at 4 C. Sections were then washed in PBS-T and incubated
for 45 min at room temperature with a biotinylated secondary
antibody (Vector Labs, UK). After washing, cells were incubated
ﬁrst with Streptavidin-HRP (Vector Labs) and then with 3,30-diam-
inobenzidine (DAB) chromogenic substrate (Vector Labs). Cells
were then observed in an in an Axioplan Imager Z1 microscope
(Zeiss).
2.11. Blood vessel quantiﬁcation
After H&E staining, sections were observed in an Axioplan Ima-
ger Z1 microscope and analyzed for blood vessels using Axiovision
software (Zeiss). The number of perfused blood vessels was
counted in the periphery of the implants within a 200 lm distance
(Supplemental Fig. 2). Three different sections with two cuts per
sample (n = 6) were used in this procedure.
2.12. Statistical analysis
In vitro data was obtained from four independent experiments
with three replicates for each condition and averaged. Standard
deviation is reported as a measure of sample deviation. Statistical
analysis of blood vessel quantiﬁcation was performed using one-
way ANOVA test with the Tukey–Kramer method as a post-hoc
pairwise comparison test. The statistical analysis of the quantita-
tive real-time RT-PCR results was performed using the Student’s
t-test for n = 4. Values were considered statistically signiﬁcant for
p < 0.05.
3. Results
3.1. CBMNC phenotype
The expression proﬁle of CD14, CD45, CD34, CD31, CD90, CD105
and CD73 markers in the isolated human CBMNCs was determined
by ﬂow cytometry (Fig. 1). The isolated cells expressed the hema-
topoietic marker CD34 (1.8%), the monocytic marker CD14 (4.94%),
the CD90 (6.27%) and the CD105 (7.8%) surface proteins. In addi-
tion, 13.8% of the population was positive for the expression of
CD73, while 4.9% expressed the endothelial marker CD31. As ex-
pected, almost all of the mononuclear fraction (close to 93%) was
positive for CD45 (not shown).
3.2. Co-culture characterization
The uptake of the DiI-AcLDL was assessed after 7 and 21 days of
in vitro co-culture. Cells with internalized DiI-AcLDL were ob-
served throughout the surface of the membranes and without
any speciﬁc organization (Fig. 2). The morphology and distribution
of cells did not change throughout the time of co-culture. A similar
cellular distribution was observed when cells in the co-culture
were stained for CD31 and vWF markers (Fig. 2). As for the
DiI-AcLDL, the pattern of expression of CD31 and vWF was similar
for all the tested co-culture times.
The quantiﬁcation of the transcripts for the genes of interest
was also performed after 7 and 21 days of co-culture (Fig. 3). The
expression level of osteogenic genes, osteopontin, osteocalcin and
collagen I, did not change in relation with monocultures for the
same time period. On the contrary, the expression of vWF, VE-cad-
herin and CD31 genes signiﬁcantly increased when compared to
monocultures for the same time period. The variation of the
expression of vWF for 7 days of co-culture was of 2.8-fold, while
for 21 days of co-culture the fold change was of 2.7. In the case
of the VE-cadherin gene, for 7 days of co-culture the expression
varied 3.0-fold while for 21 days of co-cultures there was a change
of 13.5-fold. Regarding the CD31 gene expression a positive
Fig. 1. Flow cytometry analysis of CBMNCs immediately after isolation and prior to seeding. Cells were gated to exclude dead cells, platelets and debris of erythrocytes. The
black lines represent stained cells; grey lines are the controls. The percentage of positive cells for each marker is indicated in the graph.
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variation of 3.3-fold was detected after 7 days of co-culture, while
for 21 days of co-culture, the variation was of 9.3-fold.
3.3. In vivo performance
The nature of the host reaction was analyzed based on the his-
tological and immunohistological characterization of the tissues
surrounding the different implants recovered (Fig. 4). The histolog-
ical processing altered the morphology of the membranes and their
localization in the tissue. More speciﬁcally, the size of the con-
structs decreased after treatment for histological analysis. There-
fore, we have marked the tissue–construct interface with black
dashes. The histological evaluation of the obtained sections
showed no particular differences between the co-cultured
(Fig. 4A–H) and monocultured (Fig. 4I–L) CRG membranes for 7
and for 21 days in vitro, for each implantation period. A signiﬁcant
inﬂammatory inﬁltrate surrounded the membranes at day 7 of
implantation of both systems co-cultured in vitro for 7 (Fig. 4A)
and 21 (Fig. 4C) days.
This inﬁltrate was characterized by the presence of some poly-
morphonuclear neutrophils, of a signiﬁcant number of macro-
phages, either resident or recruited from circulation, and some
foreign body giant cells (FBGCs) and lymphocytes (Fig. 4E and G).
The inﬂammatory inﬁltrate around the membranes co-cultured
in vitro for 21 days was surrounded by vascularized adipose tissue
(Fig. 4C and G).
After 21 days of implantation of the membranes, the extension
of the inﬂammatory inﬁltrate clearly increased (Fig. 4B, D, J and L)
as compared with the early implantation time period. The presence
of many mononuclear cells, similarly to the early time period
(Fig. 4F and H), was observed. Moreover, macrophages fused to-
gether, forming FBGCs, lymphocytes maintained their apparent
activation status, and some plasma cells were identiﬁed.
Perfused blood vessels around the implants with the co-cul-
tures were found to possess cells positive for human CD31 marker
(Fig. 5A–D) while this was not the case of the implants with the
monocultures of hASC-derived osteoblasts (Fig. 5E–H).
Blood vessels were quantiﬁed in the periphery of the implants
within a 200 lm distance for all the conditions, with and without
UCB MNC (Fig. 6). The number of vessels did not signiﬁcantly vary
with the in vitro culture and implantation times. However, the
number of blood vessels was always greater when MNCs from cord
blood were present. This difference was statistically signiﬁcant
when comparing the co-culture conditions and their respective
monoculture control.
Fig. 2. Co-cultures of osteoblasts and CBMNCs on the carrageenan membranes after 7 and 21 days. (A) Endothelial cell markers, CD31 (red) and vWF (green) were detected by
immunocytochemistry. ASC-derived osteoblast controls are shown (Ctrl). (B) DiI-AcLDL (red) staining identiﬁes cells from the phagocytic and endothelial lineages. Nuclei
were stained with DAPI (blue).
Fig. 3. Quantitative real-time RT-PCR of osteopontin (OP), osteocalcin (OC),
collagen I (COL I), vWF, VE-cadherin (VE-Cd) and CD31 transcripts in co-cultures
of osteoblasts and CBMNCs on carrageenan membranes after 7 and 21 days.
⁄p < 0.001 in relation to the monoculture controls.
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4. Discussion
UCB has been shown to contain endothelial progenitors that can
be used to promote the vascularization of bone tissue engineered
constructs [45]. Furthermore, current cord blood cryopreservation
techniques allow the preservation of the potential of endothelial
progenitors to be isolated from this source [46,47]. Reports show-
ing the positive inﬂuence of diverse populations of the UCB mono-
nuclear fraction in the behavior of EPCs have also reinforced the
potential of this cell source [17,48]. Mononuclear fractions of
peripheral blood depleted of CD14+ monocytes lose the ability to
form colony forming unit-endothelial cells (CFU-ECs) [48]. In fact,
CD14+ cells have been suggested to be pro-angiogenic [17] and
capable of differentiating into endothelial cells [16]. Furthermore,
T cells were proven to be essential to the CFU-EC formation by
CD14+ cells [17]. Using MNCs from cord blood for vascularization
purposes could then be an advantageous alternative to the typi-
cally used isolation of its speciﬁc sub-populations [7].
Several co-culture constructs of EPCs with MSCs/osteoblasts
have been described for bone TE [45,49,50]. Although most of them
successfully lead to increased vascularization of their constructs
because of EPCs, the isolation and culture of these cells is a long
and complex process. This work therefore proposes the use of
the complete mononuclear fraction of UCB in order to be able to
deﬁne a co-culture system carrying functional endothelial
progenitors.
The present work allowed veriﬁed that osteoblasts obtained
from adipose-derived stem cells support the survival of endothelial
progenitors present in the mononuclear fraction of UCB. Taichman
and colleagues [33] previously demonstrated how osteoblasts can
support the maintenance of hematopoietic progenitors in vitro. La-
ter Jung et al. [32] proved that this supportive effect of osteoblasts
required direct cell–cell contact. We hypothesized that osteoblasts
can have a similar action on the endothelial progenitors present in
the mononuclear fraction of the UCB. Throughout the culture
times, the monolayers of osteoblasts supported the culture of
CD31+ and vWF+ cells and of cells capable of uptaking DiI-AcLDL.
These properties are commonly used to deﬁne EPCs; however,
blood monocytes have been shown to present these markers under
angiogenic conditions [48,51]. In addition, overexpression of the
Fig. 4. Histological characterization of carrageenan membranes with co-cultured hASCs-derived osteoblasts and CBMNCs (co-cultures) (A–H) and monocultures of hASCs-
derived osteoblasts (controls) (I–L) in vitro for 7 (A, B, E, F, I, J) and 21 (C, D, G, H, K, L) days, and after 7 (A, C, E, G, I, K) and 21 (B, D, F, H, J, L) days of implantation. Implant
sections were stained with hematoxylin–eosin. The black dashes mark the construct–tissue interface before histological processing. (E)–(H) represent the zoomed areas
indicated in (A)–(D).
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endothelial genes vWF, CD31 and VE-cadherin was detected in
comparison with monocultures of MNCs under the same culture
conditions and was more signiﬁcant in the case of CD31 and VE-
cadherin genes after 21 days of co-culture. This result for VE-cad-
herin is particularly remarkable as its expression is strongly linked
to the maintenance of the integrity of new blood vessels [52].
Although striking, this promotion of the expression of endothelial
genes is not unexpected. In fact osteoblasts produce factors, such
as VEGF [31], that are capable of inducing the endothelial pheno-
type from progenitors [7]. Furthermore, the ECM deposited by
osteoblasts is composed of ﬁbronectin which may support the
adherence of endothelial progenitors from the CBMNCs [53]. Fuchs
and colleagues [50] have in fact demonstrated that outgrowth
endothelial cells, a type of EPC, have increased endothelial activity
when co-cultured with osteoblasts.
Unlike the endothelial lineage-related genes, the expression of
the osteogenic genes osteopontin, osteocalcin and collagen I
Fig. 5. Immunohistological characterization of carrageenan membranes with co-cultured hASCs-derived osteoblasts and CBMNCs (co-cultures) (A–D) and monocultures of
hASCs-derived osteoblasts (controls) (E–H) in vitro for 7 (A, B, E, F) and 21 (C, D, G, H) days, and after 7 (A, C, E, G) and 21 (B, D, F, H) days of implantation. Immunostaining was
performed to localize human CD31 marker around the implant. Sections were counterstained with hematoxylin. The black dashes mark the construct–tissue interface before
histological processing.
Fig. 6. Quantiﬁcation of blood vessels within 200 lm around the surface of the
implanted membranes. Implanted carrageenan membranes with co-cultures (co-
culture) and with osteoblast monocultures (Ctrl) were compared. ⁄Statistical
signiﬁcance at p 6 0.05.
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remained unchanged, which is not unexpected as the osteoblastic
supporting cells were fully differentiated at the time of the co-cul-
ture set-up. Co-culture systems established with MSCs or other
osteoblast progenitors instead of osteoblasts are probably more
likely to be inﬂuenced by the other cell types. This was demon-
strated by Fedorovich and colleagues [54] in a co-culture model
where EPCs promote the osteogenic differentiation of MSCs, while
these promote the proliferation of the EPCs. In our strategy, com-
pletely differentiated cells were the ones we wanted to test.
CRGs are natural sulfated polysaccharides are a widely used in
the food industry [55]. Recently, kappa-CRGs have been proposed
for regenerative medicine purposes [38–40], presumably due to
their favorable mechanical properties and anticoagulant effect
[56]. We hypothesized that membranes produced using a kappa–
iota hybrid type of this natural polymer could act as carriers to test
the functionality of the developed co-cultures in vivo. To our sur-
prise, a very strong and progressive inﬂammatory reaction was de-
tected after implantation of the CRG membranes. Furthermore, the
amount and nature of the inﬂammatory inﬁltrate did not vary with
the implant type (CRG membranes only withhASC-derived osteo-
blasts or CRG membranes with hASC-derived osteoblasts co-cul-
tured with CBMNCs), which seems to indicate that the cellular
component did not signiﬁcantly inﬂuence the inﬂammatory reac-
tion. Solutions of CRG from kappa, iota and lambda types have
been used to induce acute inﬂammation in animal models [57–
59]. Moreover, as Tobacman thoroughly reviewed [55], the inges-
tion of CRG, used in the food industry, is associated with the onset
of several lesions in the gastrointestinal tract in several animal
models. Its use as a food additive is in fact very controversial due
to health concerns [55,60,61]. Additionally, an acute inﬂammatory
response, characterized by an abundant neutrophilic exudate and
high levels of c-reactive protein, was reported after implanting gel-
atin/kappa-CRG (55%/45% w/w) sponges. The intensity of the reac-
tion was nevertheless milder when the weight percentage of CRG
was lowered to 9% suggesting a dose-dependent inﬂammatory ef-
fect of this polysaccharide. A similar acute inﬂammatory response
that progressed to chronic inﬂammation was observed after
implanting our membranes made of hybrid CRG. Although these
results impair their potential use for TE or regenerative medicine
purposes, the functionality of the deﬁned co-culture system was
nevertheless demonstrated.
A link between chronic inﬂammation and angiogenesis is well
described in the literature [62–64] as there are many factors se-
creted by inﬂammatory cells that can act on EPCs [65,66]. Further-
more, differentiation of EPCs and their contribution to angiogenesis
in pathological situations has also been observed experimentally
[8,67]. Although the animal model used in the present work lacks
an adaptive immune response, it is highly capable of presenting a
strong inﬂammatory response. Human CD31+ cells were found
forming the wall of perfused blood vessels in the vicinity of the im-
plant for all the times of culture. This suggests that an endothelial
progenitor population present in the co-cultures was able to re-
spond to the stimuli present at the implantation site and to mi-
grate out of the membranes and differentiate, and to contribute
to angiogenesis in the inﬂammatory setting. These results also
demonstrate the usefulness of the mononuclear fraction of UCB
as a source of endothelial cells or endothelial progenitors without
previous selection. In addition to the proven active participation of
transplanted CBMNCs in new blood vessels formed, their impact
over the number of vessels formed around the implants was also
demonstrated. A signiﬁcantly higher number of vessels formed
around the implants containing the CBMNCs than around the im-
plants only with hASC-derived osteoblasts.
Overall, this work suggests that hASC-derived osteoblasts can
support the maintenance of endothelial progenitors present in
CBMNCs. Furthermore, the latter can be used to increase vascular-
ization in vivo in an inﬂammatory setting. This can potentially be
very interesting for future bone TE approaches although more
studies need to be made, especially using biomaterial carriers/sup-
ports capable of eliciting host reactions with different degrees of
severity.
5. Conclusions
The current work showed that hASC-derived osteoblasts sustain
in vitro the survival of endothelial progenitors present in the
mononuclear fraction of UCB in a direct co-culture system estab-
lished using CRG membranes as supports. Although it is proven
that the produced CRG membranes are not suitable for biomedical
applications, the functionality of the cells from UCB co-cultured
with osteoblasts was demonstrated in an in vivo inﬂammatory set-
ting. The presence of human CD31+ cells in blood vessels around
the implant, as well as the increased number of blood vessels when
the mononuclear fraction of UCB was used, conﬁrms the existence
of a sub-population of that fraction that can contribute to angio-
genesis. This is an indication of the potential use of the mononu-
clear cells from the UCB, without further selection, as a source of
endothelial progenitors supported by co-culture with osteoblasts.
Acknowledgements
Financial support through the Ph.D. Grant SFRH/BD/44893/
2008 to R.P. P. by the Portuguese Foundation for Science and Tech-
nology (FCT) and through the European Union NoE EXPERTISSUES
(NMP3-CT-2004-500283) is acknowledged.
Appendix A. Figures with essential colour discrimination
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